Skip to main content

Table 4 Proportion of children with worse performance on day 9, 10 and 14 compared to day 7, in children with P. falciparum treated with AS7 or MAS7.

From: The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria

  

Day 9 - Day 7

Neurological Test Component

Result compared to previous test

AS7 N = 39

MAS7 N = 39

P*

Box

Worse

17.9 (7)

20.5 (8)

1.000

Cube

Worse

15.4 (6)

28.2 (11)

0.272

Ring

Worse

12.8 (5)

20.5 (8)

0.545

Coin

Worse

12.8 (5)

12.8 (5)

1.000

Behaviour

Worse

33.3 (13)

30.8 (12)

1.000

Tone

Decreased

46.2 (18)

53.8 (21^)

0.651

  

Day 10 - Day 7

  

AS7 N = 39

MAS7 N = 39

P*

Box

Worse

12.8 (5)

15.4 (6)

1.000

Cube

Worse

23.1 (9)

33.3 (13)

0.457

Ring

Worse

5.1 (2)

20.5 (8)

0.087

Coin

Worse

7.7 (3)

12.8 (5)

0.711

Behaviour

Worse

25.6 (10)

30.8 (12)

0.802

Tone

Decreased

38.5 (15)

50 (19^)

0.363

  

Day 14 - Day 7

  

AS7 N = 38

MAS7 N = 38

P*

Box

Worse

15.8 (6)

21.1 (8)

0.768

Cube

Worse

23.7 (9)

28.9 (11)

0.795

Ring

Worse

15.8 (6)

2.6 (1)

0.108

Coin

Worse

10.5 (4)

7.9 (3)

1.000

Behaviour

Worse

26.3 (10)

28.9 (11)

1.000

Tone

Decreased

34.2 (13)

56.8 (21^)

0.084

  1. *comparison of 2 × 2 for AS7 vs MAS7
  2. ^Tone 1 less than N for MAS7 on each comparison